Eloxx Pharmaceuticals, Inc. announced that it will receive $3,175,000 total gross proceeds in a round of funding from returning lender Hercules Capital IV, L.P., fund managed by Hercules Capital, Inc. on July 11, 2024. The company will receive loan bridge financing in the transaction. The transaction is expected to close on July 12, 2024.

As on the same date, the company has received $500,000 in its first tranche.